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Background: Neuroimaging investigations of white matter abnormalities in subjects at genetic risk for bipolar
disorders (BD) potentially predating the onset of BD offer several advantages. They are not confounded by the
presence of illness duration or previous treatment with medication and may ultimately inform evaluation of risk for
subsequent development of BD and subsequent therapeutic intervention.
Discussion: Although a number of imaging studies in subjects at genetic risk for BD are available the results are
conflicting and no reliable structural markers of genetic liability to bipolar disorders have been proposed. We
debate that white matter pathology may be central to the genetic risk to develop BD. Thus, white matter
abnormalities detectable in HR subjects but not in controls may reflect genetically driven trait markers. Similar
abnormalities may be also evident both in the HR and in BD, suggesting the possibility of genetic risk factors
shared by both groups. Conversely, white matter alterations observed in BD patients but not in HR and controls
can be interpreted as state markers.
Summary: We suggest that white matter alterations may represent endophenotypes and neurobiological markers
intermediate between the underlying susceptibility genes and the clinical expression of BD.Background
A number of structural brain imaging studies and meta-
analytic reviews have shown that white matter reduc-
tions are consistently found in bipolar disorder [1]. A
meta-analysis of 98 structural imaging studies showed
that bipolar disorder was associated with lateral ventricle
enlargement and increased rates of deep white matter
hyperintensities [2]. Moreover, in a recently published
tract-specific diffusion-tensor imaging (DTI) study by
Benedetti et al. it was shown that patients with BD had
significantly decreased average fractional anisotropy (FA)
and increased average mean diffusivity in the majority of
the white matter (WM) fiber bundles [3].Discussion
Neuroimaging investigations of structural and functional
brain abnormalities in subjects at genetic risk for bipolar
disorder (BD) offer several advantages. They are not
confounded by illness duration or exposure to previous* Correspondence: stefan.borgwardt@kcl.ac.uk
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distribution, and reproduction in any mediumtreatments and may ultimately inform evaluation of risk
for subsequent development of BD and subsequent
therapeutic intervention [4]. Although a number of im-
aging studies in subjects at high risk (HR) for BD are
available, the results are conflicting and no reliable im-
aging markers of genetic liability to BD is clinically avail-
able yet [5-8].
In a recent systematic meta-analysis of neuroimaging
studies of 996 HR subjects for BD and 1258 controls, we
confirmed inconclusive structural findings but increased
neurofunctional response during cognitive tasks in the
prefrontal and temporo-insular regions [9]. On the basis
of the study by Benedetti et al. [3] it is possible to specu-
late that temporo-limbic white matter (WM) alterations
may alter the neurofunctional connectivity and ultim-
ately the regional response during cognitive tasks. Spe-
cifically, region-of-interest magnetic resonance imaging
(MRI) studies of twins found decreased left hemispheric
WM volume in either BD patients or co-twins (HR)
compared with control twin subjects [10]. This indicated
that genes involved in the etiology of BD may contribute
to the WM decreases found in BD patients and in their
co-twins (HR) (trait markers) [11]. However, other MRIMed Central Ltd. This is an Open Access article distributed under the terms of
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WM alterations in the HR as compared to controls
[12,13] or to BD [14]. Others suggested more circum-
scribed and limited WM alterations in the major tracts
of the brain [15] in line with the findings of Benedetti
et al. [3]. DTI studies in the HR group showed reduced
FA in the superior longitudinal fasciculus as compared
to controls [6] and FA in HR intermediate to controls
and BD patients [16]. Significant reductions in the num-
ber, density, and size of glial cells could be reflected in
reduced WM tissue and signal hyperintensities, which
are often reported in HR subjects [6].
The genetics of bipolar disorder is complex and rela-
tives are most likely to carry some risk allels [11], un-
affected relatives of BD patients are likely to share some
susceptibility genes with affected patients. We therefore
suggest that WM alterations may represent endopheno-
types and neurobiological markers intermediate between
the underlying susceptibility genes and the clinical ex-
pression of BD. A recently published study of monozy-
gotic and dizygotic twin pairs revealed segregating
genetic liabilities specifically associated with thicker right
parietal cortex in schizophrenia and larger intracranial
volume for BD [7]. However, disruptions in WM integ-
rity have been implicated as endophenotype in schizo-
phrenia and evidence includes neuroimaging studies of
first-episode and chronic patients that report WM vol-
ume reductions and structural abnormalities, as well as
myelin-related gene abnormalities [17]. Overlapping
WM alterations between these two HR groups raises the
possibility that schizophrenia and bipolar disorders share
common endophenotypes [18-21].
Summary
We suggested that white matter alterations may repre-
sent endophenotypes and neurobiological markers inter-
mediate between the underlying susceptibility genes and
the clinical expression of BD. Disturbed WM integrity in
patients with BD will be better elucidated by imaging
studies, investigating larger and more homogenous sam-
ples and employing longitudinal designs to dissect
neurobiological abnormalities that are underlying traits
of the illness from those related to psychopathological
states such as episodes of mood exacerbation or
pharmacological treatment. Moreover, there should be
more direct comparisons between HR schizophrenia and
HR BD groups. Similar to clinical [22,23], cognitive [24]
and imaging [25-28] HR studies for schizophrenia, bio-
markers of risk that differentiate those who will go on to
develop BD from those that will not are needed. Add-
itionally, future tractography studies following up genetic
versus clinical HR samples are required to elucidate
these issues and eventually clarify the role played by
WM alterations in the development of the diseases.Competing interests
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